BHF - Majority of heart attack programmes failing to meet minimum standards
More than two-thirds (70%) of heart attack programmes are failing to meet the minimum requirements for patient care, according to BHF research.
Cardiac rehabilitation services can help heart attack patients recover and reduce their risk of another major heart event. There are hundreds of programmes spread across the UK and the majority are based at hospitals.
The study, published in Open Heart, is the first of its kind and assessed 170 programmes across England, Wales and Northern Ireland, and found that just 52 met at least five of the six national minimum standards.
The criteria included meeting minimum standards on patient access, waiting times and duration of rehabilitation.
Around 66,000 heart patients took part in rehabilitation in 2014/15, an increase of 27% since 2009 (51,000) according to the most recent National Audit of Cardiac Rehabilitation. This means that half of all eligible patients are now accessing cardiac rehabilitation services for the first time since records began.
Rehabilitation can help reduce the number of deaths by 18 per cent over the first six to twelve months and can cut readmissions to hospital by a third (31%).
It’s recommended that heart attack and angioplasty patients start cardiac rehabilitation within 33 days, but just half of programmes are meeting this target.
Reduce risk of heart attack
Cardiac rehabilitation offers physical activity support and lifestyle advice, such as exercise classes and dietary guidance, to help people living with heart disease manage their condition and reduce their risk of associated heart events.
Dr Mike Knapton,BHF Associate Medical Director, said: “This research shows the worrying extent to which cardiac rehabilitation services are failing heart patients across the UK, putting them at increased risk of having another potentially fatal heart attack.
“These services are paramount in a patients’ physical and mental recovery and the programmes which are meeting recommendations help save lives.
“Services across the UK need to ensure that at the very least, they are meeting the basic, minimum national standards of care that every heart attack patient should expect to receive.”
Latest News from
Age UK comments on Dispatches investigation into Bupa care homes20/06/2017 12:35:00
Age UK has commented on the Channel 4 Dispatches programme from Monday 19 June 2017, 'Bupa Care Homes Undercover'.
Care system 'buckling' says Age UK as major care homes investigation launches15/06/2017 10:35:00
A recent study into the quality of care homes which has sparked a much wider legal investigation has been called 'a manifestation of our buckling social care system' by Age UK.
Diabetes UK - Brits failing to meet the recommended daily allowance of fruit and veg13/06/2017 09:35:00
A new survey* commissioned by Diabetes UK to promote its Food you love healthy eating campaign in Diabetes Week (Sunday 11 June to Saturday 17 June), has found that 66 per cent of adults eat three or fewer portions of fruit and/or vegetables a day – well below the recommended five portions - and 46 per cent won’t eat any fruit at least three days a week.
CRUK - Combining immunotherapies could benefit some aggressive breast cancers09/06/2017 10:15:00
Using two immunotherapy drugs together could help treat some patients with an aggressive form of breast cancer, according to an Australian study.
CRUK - Two clinical trials show promise with different targeted drugs for lung cancer07/06/2017 14:10:00
Two drugs targeting different gene faults in lung cancer have shown potential to be better than those already available, according to unpublished clinical trials.
CRUK - New chemotherapy approach offers breast cancer patients a better quality of life07/06/2017 12:10:00
The chemotherapy drug capecitabine gives patients a better quality of life and is as effective at preventing breast cancer from returning as the alternative regimen called CMF, when given following epirubicin.
CRUK - Adding abiraterone to standard treatment improves prostate cancer survival by 40 per cent06/06/2017 10:35:00
Adding abiraterone to hormone therapy at the start of treatment for prostate cancer improves survival by 37 per cent, according to the results of one of the largest ever clinical trials for prostate cancer presented at the 2017 ASCO Annual Meeting in Chicago and published in the New England Journal of Medicine on Saturday.
British Red Cross - Manchester attack – What happens after05/06/2017 16:15:00
An edition of the BRC’s Newsthink encourages young people to consider ways that the public helped each other after the explosion. It also explores the role of practical help and emotional support during and after an emergency.